Preventative Diagnostics Genotox emphasizes early disease signaling and preventative medicine through proprietary diagnostics, presenting an opportunity to position complementary testing partnerships with health systems, payers, and clinics focused on early intervention programs.

Pain and Addiction Focus With specialty expertise in pain management, addiction, psychiatry, and primary care, there is potential to cross-sell expanded diagnostic panels and monitoring solutions to integrated care networks seeking comprehensive behavioral and medical screening.

Genetic and MS Capabilities The combination of genetically guided signals, high resolution mass spectrometry, and sequencing capabilities can be packaged as a high-value, precision diagnostics suite for partners pursuing advanced biomarker identification and personalized treatment pathways.

Evidence and Outcomes Genotox promotes early intervention to reduce overdose mortality and costly ER visits; sales opportunities exist with healthcare systems and insurers seeking value-based tools that improve recovery outcomes and population health metrics.

Smaller Firm Advantage As a 51-200 employee diagnostics provider with a demonstrated rapid launch capability (e.g., at home COVID test kits previously), Genotox can be targeted for nimble pilot programs, regional partnerships, and scalable service agreements ahead of larger lab consolidations.